<DOC>
	<DOCNO>NCT02490670</DOCNO>
	<brief_summary>The purpose study compare two different preparation antibiotic call cephalexin determine essentially . The study two period . Participants receive one preparation cephalexin period . At least 7 hour pas study period . The study expect last 2 day participant , include screen follow-up .</brief_summary>
	<brief_title>A Study Cephalexin Liquid Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Cephalexin</mesh_term>
	<criteria>Participation voluntary . The body mass index participant 1827 . Participants good health status . Limits variation allow within normal value screen : blood pressure ( seat ) 139 millimeter mercury ( mm Hg ) , systolic , 89 mm Hg diastolic ; heart rate 60 100 beat per minute , respiratory rate 14 20 breath per minute . Hepatitis B C human immunodeficiency virus ( HIV ) negative . Negative drug abuse alcohol detection test approximately 12 hour administer study medication . Negative serum pregnancy test ( beta human chorionic gonadotropin ) screen urine pregnancy test approximately 12 hour administer study medication . Participants clinically significant abnormality vital sign constant record screen . Sponsor and/or site employee . Abnormal 12 lead electrocardiogram ( ECG ) opinion investigator place participant unacceptable risk study participation , Bazett correct QR interval ( QTcB ) &gt; 470 millisecond ( msec ) woman &gt; 450 msec men . Participants history cardiovascular , renal , hepatic , muscular , metabolic , gastrointestinal disease , include constipation , neurological , endocrine , hematopoietic disease , type anemia , asthma , mental disease , organic abnormality . Participants creatinine clearance &lt; 80 mL/min base CockcroftGault equation . Participants require medication study , apart medication study . Participants history dyspepsia , gastritis , esophagitis , duodenal gastric ulcer . Participants exposed medication know hepatic enzyme inducer inhibitor take potentially toxic medication within 30 day prior . Participants receive medication , include vitamin ( without medical prescription ) herbalbased remedy 30 day ( 7 halflives ) prior begin study . Participants hospitalized condition within six month begin study . Participants receive investigational drug within 60 day prior study . Participants allergic medication , food , substance . Participants require therapy nephrotoxic drug . Participants donate 450 mL blood within 60 day prior begin study . Participants history drug alcohol abuse . Participants special diet requirement cause . Participants positive pregnancy test breastfeeding . Participants hormonal treatment route . Participants record page Comisión Federal para la Protección contra Riesgos Sanitarios ( COFEPRIS ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>